28.08.2023 • NewsCovestroinvestment

Covestro Completes Construction of New Polyurethane Dispersions Site in Shanghai

Covestro has completed construction on a new production facility for polyurethane dispersions (PUDs) in Shanghai, China.

With the new capacity, the German engineering plastics manufacturer aims to meet the growing demand for environmentally compatible coatings and adhesives in the Asia-Pacific region in industries such as automotive, construction, furniture, footwear and packaging.

The plant, expected to come on stream in the first quarter of 2024, will be producing waterborne PUDs with properties equal to the performance of solvent-based types, and also grades with more circular contents.

“With this new facility we aim to offer the broadest portfolio of PUDs to support the sustainability efforts of downstream industries here in Asia Pacific,” said Thorsten Dreier, chief technology officer of Covestro. “The modular concept adopted in the construction phase will also enable us to implement future investment projects and build up capacity more efficiently to capture market demand.”

According to Covestro, the plant, which is housed at the company's Shanghai Integrated Site (CISS), was built by a service provider using modular construction methods in Nantong, Jiangsu Province. After completion, the individual modules were transported to the final site and assembled there.

Source: Covestro
Source: Covestro

Company

Logo:

Covestro


51368 Leverkusen
Germany

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read